The end of the natural human.

We have spent this entire series on the biology of enhancement—on the genes that can be edited, the traits that can be selected, the peacock’s tail that can be manufactured. But biology is never merely biology. Every technology that redistributes power creates a new social order, and gene editing redistributes the most fundamental power of all: the power to determine what kind of human gets born. The question is not whether this will reshape society. It is what shape the new hierarchy will take.

The Transitional Divide: Natural and Enhanced

The first phase is already visible, and it is simpler and uglier than the clan-and-guild future that follows. Unequal access to genetic technologies risks creating “genetic privilege” and new forms of biological stratification (Hosseinisa, 2025). The concern is not hypothetical. A survey study found significantly higher approval of human cognitive enhancement with reprogenetic technologies among Singaporean versus American respondents, driven by the competitive educational landscape of East Asian Confucian societies (Bmj, 2025). Where the demand is highest, the market will price accordingly. Cognitive-enhancing technologies will be launched at premium prices by tech companies, making them accessible only to affluent families (Bmj, 2025).

The result is a two-tier humanity. At the top, a genetic elite whose advantages are not merely economic or cultural but biological—encoded in every cell, transmitted to every descendant. At the bottom, the natural humans, whose unchosen genomes become a marker of exclusion. This is the “genetic underclass” that researchers have warned about: a population whose biological differences reinforce social hierarchies and whose disadvantages compound across generations (Zenodo, 2026). Unlike wealth, which can be redistributed, genetic advantage is self-reinforcing in a way that no tax policy can address. It is, as one analysis puts it, “the most durable form of inequality in human history—genetic inequality that is literally encoded in biology and transmitted across generations” (Zenodo, 2024).

The transitional divide will not be stable. It will be a period of intense competition, as the enhanced use their advantages to capture more resources, more positions, more reproductive opportunities, while the natural majority experiences what can only be described as a slow-motion displacement. And then the structure will crystallize.

This will be the end of racism, and the rise of traitism (if hereditary), or featurism (if non-hereditary).

The Clan and the Guild: The New Post-Ethnic Order

The long-term equilibrium is not a simple two-tier hierarchy. It is a return to a pre-modern social architecture, rebuilt on genetic foundations. The future belongs to two organizational forms that have existed for millennia and are now being revived by biotechnology: the clan and the guild.

The clan is the historical form of the nobility, and its genetic version is already being theorized in the enhancement literature. The logic is straightforward. If you can edit the germline, you can design a lineage. A family that invests in genetic enhancement across multiple generations is no longer a family in the ordinary sense. It is a dynasty—a group defined not by shared culture or shared language but by a shared engineered genome. The clan is post-ethnic because its membership is determined by biology, not by ancestry in the traditional sense. It is post-national because its loyalties are to the lineage, not to the state. This is the return of the aristocratic principle, but stripped of its historical accidents and rebuilt on a rational, biological foundation.

The guild is the historical form of the merchant class, and its genetic version follows a similar logic. A guild is a self-regulating association of practitioners who control access to a trade, set standards, and transmit knowledge to apprentices. The genetic guild would be an association of families who have pooled resources to edit for a common set of traits—cognitive abilities suited to a particular industry, metabolic profiles suited to a particular environment, sensory capacities suited to a particular craft. Membership is hereditary, because the traits are hereditary. The guild is post-ethnic because it recruits on the basis of genetic compatibility, not cultural background. It is post-national because its economic interests are global, not territorial.

The clan and the guild are not mutually exclusive. They are complementary. The clan provides the lineage, the long-term genetic strategy, the dynastic continuity. The guild provides the professional network, the economic infrastructure, the transmission of specialized knowledge. Together, they form the new aristocracy—not of blood in the old sense, but of engineered biology. The natural humans below them are not a rival class. They are a labor pool, a consumer market, and a demographic remainder.

Nation states will thus be under an extreme pressure to group together as regional blocs to stay relevant, as these new powerful dynasties and trade associations rise to challenge their authority.

This is not a conspiracy. It is an emergent structural logic. The same logic that produced the paterfamilias in Rome and the merchant guilds of medieval Europe will produce its genetic equivalent, because the incentives are identical: to secure advantage for one’s descendants, to control access to scarce resources, to build institutions that outlast the individual. The only difference is the substrate. The old aristocracies were built on land, on titles, on military force. The new one is built on the genome.

This will inevitably breed a new labor collective built on biological rights to enhancements considered as necessary for egalitarian outcomes, as well.

The Underground Economy: Backroom Biologics and the Genetic Black Market

Before the clan-and-guild equilibrium arrives, there will be a period of chaos—and chaos always produces a black market. The underground economy of gene therapies is already here, and it is growing faster than any regulatory apparatus can track.

The core of this economy is the biohacker movement. In 2017, Tristan Roberts injected himself with a DNA minicircle encoding a neutralizing antibody targeting HIV. The same year, Josiah Zayner livestreamed the injection of CRISPR-Cas9 targeting the myostatin gene into his own arm (Nature, 2019). These were not isolated acts of madness. They were prototypes—proofs of concept for a distributed, decentralized, patient-driven model of gene therapy that operates entirely outside the clinical trial system. The entire Slybera project—a bootleg version of the gene therapy Glybera, produced by four biohackers working in a shed in Mississippi, a warehouse in Florida, a bedroom in Indiana, and a computer in Austria—cost less than $7,000 (Nature, 2019). That is the price point of a used car. The pharmaceutical equivalent costs over a million dollars per treatment.

The regulatory response has been predictable and ineffective. California passed a law prohibiting the sale of DIY CRISPR kits unless they carry a notice stating they are not for self-administration (Nature, 2019). The FDA and the American Society for Gene Therapy issued statements warning of the dangers of homebrew treatments. But the biohackers “circumnavigated this law by promising to release Slybera for free” (Columbia, 2019). You cannot regulate a gift.

And the underground market is not limited to the ideological biohackers of the American counterculture. In China, a couple worth hundreds of millions of yuan approached an underground clinic to perform gene editing on their embryos—selecting for a male child and “high-IQ loci.” The price was two million yuan. The clinic operated entirely outside regulatory review (Wuhan, 2026). In the European Union, the EMA has issued repeated warnings about illegal advanced therapy medicinal products being sold directly to patients without authorization (Farmacja, 2025). The pattern is global, decentralized, and increasingly sophisticated.

The underground economy serves two functions. The first is access. For the wealthy who want traits that no approved clinic will provide, the black market is the only option. The second is experimentation. The biohackers are not just consumers; they are producers. They are generating data—messy, uncontrolled, ethically fraught data—on what happens when you edit human genes outside the clinic. That data will be used, eventually, by someone. The question is by whom.

The biohacker underground will eventually dethrone the currently thriving economy of narcotrafficking. The outcome of this trend is contignent on calibrating the legislation and regulation to reflect what’s actually happening rather than the emotions of the incumbents at the time of the laws being passed and the regulations being introduced.

The Uncomfortable Conclusion

The genetic class war is not a future scenario. It is a present-tense procurement problem. The technologies are real, the demand is real, and the regulatory apparatus is a patchwork of national laws that any determined actor can circumvent. The transitional divide between natural and enhanced humans is already being drawn. The clan and the guild are already being theorized, funded, and built.

And beneath it all runs the underground economy—the backroom biologics, the offshore clinics, the bedroom labs—that ensures the technology will never be contained by any single jurisdiction. The future of human evolution will not be decided by committees or treaties. It will be decided by the people who can afford it, the people who want it, and the people who are willing to break the law to get it.

The natural human is a temporary category. The question is what replaces them.